Temocillin dosing study for kidney infections in children
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the antibiotic temocillin works in children with kidney infections (pyelonephritis). It helps find the right dose to treat the infection safely and effectively, but only for kids who need hospital care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between birth and 15 years old.
- Your child must have a fever and a urinary tract infection (UTI) caused by certain bacteria (gram-negative rods).
- Your child will need to stay in the hospital for at least 48 hours.
- Your child cannot have sepsis (a severe body-wide infection), a severe kidney problem, or an allergy to penicillin-like antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new antibiotic (temocillin) to the standard treatment for gonorrhea that is not causing symptoms. It aims to see if temocillin works as well or better, and you may get either treatment.
This trial tests whether giving antibiotics through a vein for 3 days works as well as giving 3 days through a vein followed by 7 days by mouth for a first urinary tract infection (kidney infection). It may help your child recover safely while possibly reducing longer IV treatment.
This trial tests whether one dose of intravenous (IV) antibiotics is as effective as the usual multiple-dose course for children with complicated urinary tract infections (UTIs) who need IV treatment in the emergency department. It aims to reduce hospital stays and the need for repeated IV lines.
This study tests a new IV antibiotic combination (cefepime-enmetazobactam) for children with complicated urinary tract infections or kidney infections. The goal is to see how well it works and if it is safe.
This trial tests a single dose of an investigational antibiotic called gepotidacin in hospitalized children with bacterial infections who already have an IV line. The medicine is given as a powder mixed with food, and the study aims to see how well it is absorbed and tolerated.
This study compares two ways of giving antibiotics to children with sepsis: the usual short infusions versus longer or continuous infusions. The goal is to see if one approach works better or is safer.
Hear when a new Pyelonephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.